XRAY
28
2
CL
58
2
EQIX
64
2
PLD
56
8
MPC
44
-3
STI
14
-17
DE
63
3
HD
57
2
NVDA
56
-4
HSIC
56
5
HBI
59
4
EMN
60
4
SWK
64
5
RSG
71
3
PAYX
53
2
CMA
61
5
COF
60
2
WDC
47
4
PBI
69
4
PFE
23
7
XRAY
28
2
CL
58
2
EQIX
64
2
PLD
56
8
MPC
44
-3
STI
14
-17
DE
63
3
HD
57
2
NVDA
56
-4
HSIC
56
5
HBI
59
4
EMN
60
4
SWK
64
5
RSG
71
3
PAYX
53
2
CMA
61
5
COF
60
2
WDC
47
4
PBI
69
4
PFE
23
7
Financhill
Back

Genmab AS Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25

GMAB
Genmab AS

Last Price:
20.65
Seasonality Move:
5.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 26% based on the past 12 years of stock performance.
  • Genmab AS has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $20.65. The Score for GMAB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 26% based on the past 12 years of stock performance.

Genmab AS Stock Rating

Sell
25
Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 8 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
32.88
52-Week Low:
20.34

Prediction Charts

Market Cap:
13.12B
Price in USD:
20.65
Volume:
1.08M
Beta:
0.71

Technical Analysis

SMA50:
23.16
SMA100:
25.18
SMA200:
26.87
52-Wk Change:
-34.55%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 20.65 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 22.56 22.75 22.84 22.18
Nov-6 22.20 22.33 22.76 21.90
Nov-7 22.64 23.11 23.19 22.64
Nov-8 22.85 23.08 23.18 22.80
Nov-11 23.18 23.20 23.47 22.95
Nov-12 22.90 22.47 22.94 22.41
Nov-13 21.94 21.67 22.20 21.59
Nov-14 21.75 21.18 21.82 21.17
Nov-15 21.01 20.59 21.01 20.50
Nov-18 20.64 20.67 20.85 20.58
Nov-19 20.51 20.50 20.64 20.39
Nov-20 20.49 20.45 20.55 20.36
Nov-21 20.53 20.47 20.62 20.34
Nov-22 20.61 20.65 20.84 20.60

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.28 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.